Scientists discovered that inhibiting the enzyme STK17B forces multiple myeloma cells into iron-driven death and makes therapies more effective. Early mouse studies show strong potential for a new ...

R - Renal (kidney) problems: Poor kidney function is a classic sign of multiple myeloma. The disease can trigger high creatinine or increased protein in the urine, leading to frothy foamy urine or ...

Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma cancer cells, but also ...

Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma cancer cells, but also increases the effectiveness of current therapies ...

Multiple myeloma is a chronic (long-term) blood cancer that affects plasma cells made in the bone marrow, which is spongy tissue found inside bones. While people with multiple myeloma can live for ...

Iberdomide combined with standard therapies showed a statistically significant improvement in minimal residual disease (MRD) negativity rates, compared with the control arm, in patients with relapsed ...

A JAMA study finds cancer diagnoses in Americans under 50 have doubled since 1992, but deaths remain flat—raising concern about overdiagnosis.

Blood cancers, affecting blood, bone marrow, and lymphatic systems, often present subtle symptoms but are increasingly treatable with modern therapies ...